Lyophilization / Freeze drying cycle
Revolutionizing Pharmaceutical Stability with Expert Lyophilization Services
Unleash the Potential of Lyophilization
In the realm of pharmaceutical development, stability is paramount. Many APIs face instability in aqueous phases, necessitating meticulous galenic studies to ensure prolonged stability. At Eurofins CDMO, we recognize the significance of scalability and commercial viability in achieving lasting stability. Our sterile manufacturing service portfolio is designed to elevate your API's stability, driving it to a higher stage of performance. With cutting-edge development laboratories featuring state-of-the-art labscale freeze dryers, we embark on a journey to reshape drug stability.
Tailored Solutions: Your Vision, Our Expertise
At Eurofins CDMO, we offer an array of specialized services:
- Formulation Transition: Seamlessly shift from liquid to freeze-dry form, ensuring enhanced stability and sustainability.
- Solubilization and Formulation Study: Unlock the potential of injection-ready formulations, enhancing efficacy and safety.
- Optimized Freeze Drying: Streamline processes, reducing costs while optimizing freeze drying cycles.
- Cycle Development: Meticulously craft freeze drying cycles to ensure impeccable stability.
Customized for Success: Unveiling Versatility
Our expertise spans across a multitude of APIs, catering to various requirements:
- HP API and Cytotoxics: Handle high-potency APIs and cytotoxics up to OEL4 with precision, ensuring safety at every stage.
- BSL 2 Products: Cater to BSL 2 products with meticulous care, adhering to regulations.
- Regulated Molecules: Navigate the complexity of regulated molecules, like Opioids.
- Standard Molecules: Our expertise extends to standard molecules, ensuring stability across the board.
Beyond Development: Embrace the Future
At Eurofins CDMO, our commitment doesn't end with development. Once your API reaches the development stage, we're poised to manufacture your clinical stage material at pilot scale, meeting clinical phases capacity requirements or catering to Orphan Drug supply on a commercial scale.
Contact us now !
